Collegium Pharmaceutical, Inc. (COLL)
47.47
-0.44
(-0.92%)
USD |
NASDAQ |
Dec 09, 10:52
Collegium Pharmaceutical Shareholders Equity (Quarterly): 274.81M for Sept. 30, 2025
Shareholders Equity (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Shareholders' Equity Definition
Shareholder's Equity is a main portion of the balance sheet of a company that measures the net value of a company. The reason for this is because the from an accounting perspective, the balance sheet equation is Shareholder's Equity = Assets - Liabilities. A few examples of shareholder's equity of a company include retained earnings, paid in capital, and preferred stock.
Shareholders Equity (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Shareholders Equity (Quarterly) Benchmarks
| Catalyst Pharmaceuticals, Inc. | 920.24M |
| Alnylam Pharmaceuticals, Inc. | 233.89M |
| Altimmune, Inc. | 185.60M |
| Vertex Pharmaceuticals, Inc. | 17.32B |
| Viking Therapeutics, Inc. | 713.03M |
Shareholders Equity (Quarterly) Related Metrics
| Total Assets (Quarterly) | 1.607B |
| Total Liabilities (Quarterly) | 1.333B |
| Debt to Equity Ratio | 3.407 |
| Current Ratio | 1.355 |
| Net Debt Paydown Yield | -6.82% |